NIH Infectious Disease Leadership Shake-Up Raises Concerns Amid Ebola, Hantavirus Outbreaks 
Medicare to Cover GLP-1 Weight-Loss and Diabetes Drugs Starting July 1 
Bayer Rules Out Monsanto Spin-Off as Roundup Lawsuits Continue to Mount 
Asian Stocks Advance as Nikkei Nears Record High Ahead of Fed Decision 
Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone 
German Industry Employment Falls to Lowest Level in a Decade 
Supreme Court Blocks 5th Circuit Ruling on Abortion Pill Access 
ByteDance Eyes Iluvatar, Baidu AI Chips Amid China’s AI Push 
Hantavirus Cruise Ship Outbreak Triggers Global Health Alert 
DOJ Sues Virginia Over Law Enforcement Mask Ban 
Australia Sues 3M for Over A$2 Billion Over PFAS Firefighting Foam Contamination 
Trump Administration Urges Judge to Allow UFC Event on White House Lawn 
China Industrial Output Beats Forecasts as Domestic Demand Weakens 
Saudi Aramco Explores Sulphur Business Stake Sale to Raise Billions 
Trump Administration Delays DeepSeek and CXMT Trade Blacklist Designations Amid U.S.-China Tensions 
DOJ Sues UCLA Over Alleged Antisemitism and Hostile Campus Environment 
Qantas Nears Launch of World’s Longest Non-Stop Flights to London and New York 
Johnson & Johnson offered $8.9 billion to settle years-old lawsuits claiming that its talcum powder products caused cancer.
The New Jersey-based pharmaceutical giant described their proposal, which still needs a bankruptcy court’s approval, as an equitable and efficient resolution to all claims arising from cosmetic talc litigation.
If approved by the bankruptcy court and a majority of the claimants, the $8.9 billion deal would rank alongside those reached by cigarette corporations and opioid producers as one of the largest product liability settlements ever in the US
Thousands of claims have been filed against J&J because of talcum powder that may have contained traces of asbestos and was linked to ovarian cancer.
The company has never acknowledged wrongdoing, but as of May 2020, it no longer sells its talc-based baby powder in the US and Canada.
The $8.9 billion would be paid to the tens of thousands of claimants over 25 years through a J&J subsidiary, LTL Management LLC, which was set up to address the claims and has filed for bankruptcy protection.
A previous settlement involving LTL was rejected by an appellate court.
